Drugs of Abuse 9 Panel, Urine - Screen Only
0090453
 
Ordering Recommendation
Mnemonic
CDTI9
Methodology
Qualitative Enzyme Multiplied Immunoassay Technique
Performed
Sun-Sat
Reported
1-2 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Random urine.  
Specimen Preparation
Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.  
Remarks
 
Stability
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years  
Reference Interval
Drugs Covered and Cutoff Concentrations
Drugs Screen
Marijuana 20 ng/mL
Cocaine 150 ng/mL
Opiates 300 ng/mL
Oxycodone 100 ng/mL
Phencyclidine 25 ng/mL
Amphetamines 300 ng/mL
MDMA (Ecstasy) 500 ng/mL
Barbiturates 200 ng/mL
Benzodiazepines 200 ng/mL
Methadone 150 ng/mL
Propoxyphene 300 ng/mL
Interpretive Data
This is a screening test only. Positive results are not automatically reflexed to a confirmatory test (GC/MS and/or LC-MS/MS) unless requested separately. Confirmatory testing for drugs and/or drug classes detected by this screening test is recommended.

The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

The following opioids are not detected in this test: fentanyl, buprenorphine, meperidine, tramadol, and tapentadol. A comprehensive panel that includes these opioids is available or individual opioid testing can be ordered. Refer to aruplab.com for test information.

For medical purposes only; not valid for forensic use.
Note
To order testing for individual opioids, refer to Fentanyl and Metabolite - Confirmation/Quantitation - Urine (ARUP test code 0092570), Buprenorphine and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2002749), Meperidine and Metabolite - Confirmation/Quantitation - Urine (ARUP test code 2002760), Tramadol and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2002736). For the comprehensive panel, refer to Pain Management Drug Panel by High-Resolution Time-of-Flight Mass Spectrometry and Enzyme Immunoassay, Urine (ARUP test code 2007479).
CPT Code(s)
80101 x9 (HCPCS:G0431)
Components
Component Test Code*Component Chart Name
0090381Amphetamines, Urine
0090382Barbiturates, Urine
0090383Benzodiazepines, Urine
0090386Creatinine, Urine
0090387Propoxyphene, Urine
0090388Cocaine, Urine
0090389Methadone, Urine
0090396Opiates, Urine
0090397Phencyclidine, Urine
0090398Marijuana, Urine
0090418CDTI 9 Comments
2004776Oxycodone, Urine
2004778MDMA, Urine
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • Amphetamines, Urine
  • Barbiturates, Urine
  • Benzodiazepines, Urine
  • Cocaine, Urine
  • Marijuana, Urine
  • MDMA, Urine
  • Methadone, Urine
  • Opiates, Urine
  • Oxycodone, Urine
  • Pain Management
  • Phencyclidine, Urine
  • Propoxyphene, Urine